Equities

Shanghai Haoyuan Chemexpress Co Ltd

688131:SHH

Shanghai Haoyuan Chemexpress Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)25.10
  • Today's Change0.46 / 1.87%
  • Shares traded1.42m
  • 1 Year change-32.16%
  • Beta--
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4754721,034
Total Receivables, Net544416187
Total Inventory1,145911352
Prepaid expenses161914
Other current assets, total8.154.873.41
Total current assets2,1881,8231,590
Property, plant & equipment, net1,2181,096600
Goodwill, net30130115
Intangibles, net11910141
Long term investments1348983
Note receivable - long term------
Other long term assets------
Total assets4,1923,5982,385
LIABILITIES
Accounts payable285287186
Accrued expenses11310948
Notes payable/short-term debt56825127
Current portion long-term debt/capital leases945125
Other current liabilities, total10312335
Total current liabilities1,164822322
Total long term debt425366165
Total debt1,087669218
Deferred income tax15160.92
Minority interest171214
Other liabilities, total626160
Total liabilities1,6831,278562
SHAREHOLDERS EQUITY
Common stock15010774
Additional paid-in capital1,6891,6341,326
Retained earnings (accumulated deficit)667577423
Treasury stock - common------
Unrealized gain (loss)1.26----
Other equity, total1.902.34(1.6)
Total equity2,5092,3201,822
Total liabilities & shareholders' equity4,1923,5982,385
Total common shares outstanding211209204
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.